July 2013

Meso Foundation’s New CEO

The Meso Foundation has a new CEO! Melinda Kotzian, who has thus far been the Chief Operating Officer, will now serve as the Foundation’s first Chief Executive Officer. This change in title provides Melinda with authority to fully perform all operational, administrative and executive duties.
Mary Hesdorffer, Nurse Practitioner, remains the organization’s Executive Director, and together […]

Donating to the Meso Foundation through the Combined Federal Campaign (CFC)

If you are a federal employee (including military personnel), you are eligible to participate in the Combined Federal Campaign’s (CFC) fundraising drive. The CFC allows federal employees to make tax-deductible donations to their charity of choice directly through payroll deductions.
The Mesothelioma Applied Research Foundation is eligible to receive your donations. In order to ensure that […]

Mesothelioma Mobilization in Britain

by Laurie Kazan-Allen
The publication of an article entitled “Mesothelioma – The British Disease” in mid-June, 2013 set the tone for a summer of legislative, political, and public mobilization on asbestos. As groups representing asbestos victims lobbied politicians over the unfairness of provisions in the Mesothelioma Bill, members of the House of Lords tabled amendments to […]

A Fundraising Campaign is Born

by Erica Ruble, Fundraising Coordinator, Mesothelioma Applied Research Foundation
I lost my hero and father, Lance S. Ruble, to mesothelioma on August 16, 2008. Determined to make a difference and learn more about the disease, I attended my first Symposium in Washington, DC in 2009. It was at this conference that I was inspired by the […]

The Anatomy of Clinical Trials for Mesothelioma

Recently, we had the honor to interview Melissa Culligan, RN, BSN, MS, a thoracic surgery nurse with specialized experience designing clinical trials. To listen press PLAY in the above podcast box (it may take a minute for the podcast to load).
In a cancer like mesothelioma, for which there is only one FDA-approved treatment, clinical trials […]